Research peptides · For laboratory and scientific research in vitro · Not medications · Not approved for consumption · Adults only (18+)
FOXO4-DRI (senolytic peptide)
In plain language
D-retro-inverso peptide developed at Erasmus MC (de Keizer, 2017). Selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 interaction.
For researchers
Competitively binds FOXO4 in senescent cells and releases p53, which induces apoptosis. Healthy cells unaffected — selective senolytic effect.
Scientific literature
Information about FOXO4-DRI is based on published scientific research and is intended for research purposes. Not medical advice.
Products related to this peptide are for in vitro laboratory research only. Not approved for human consumption.
Other peptides
Available products
Not a drug — for in vitro research
Quick reference
